Status:
RECRUITING
DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis
Lead Sponsor:
University of Minnesota
Conditions:
Acute Pancreatitis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to identify novel blood-based biomarkers for prediction and diagnosis of infected pancreatic necrosis (IPN) in patients with necrotizing pancreatitis (NP). Acute pancreati...
Eligibility Criteria
Inclusion
- Adults aged \>18 years.
- Diagnosis of NP based on CECT.
Exclusion
- recurrent AP
- pancreatic cancer
- pregnancy, lactation
- solid organ transplant
- immunodeficiency disorders like AIDS.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06899087
Start Date
July 1 2025
End Date
December 1 2026
Last Update
July 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455